Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Molluscicides Market

ID: MRFR/Agri/3813-HCR
110 Pages
Snehal Singh
Last Updated: April 06, 2026

Molluscicides Market Size, Share, Industry Trend & Analysis Research Report Information By Type (Chemical Metaldehyde, Methiocarb, Ferric Phosphate, Biological, and Others), By Form (Dry and Liquid), By Crop Type (Vegetables & Fruits, Cereals & Grains, Oilseeds & Pulses, Ornaments and Turf, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Molluscicides Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Agriculture
  50.     4.1.2 Horticulture
  51.     4.1.3 Aquaculture
  52.     4.1.4 Public Health
  53.   4.2 Healthcare, BY Formulation Type (USD Million)
  54.     4.2.1 Granular
  55.     4.2.2 Liquid
  56.     4.2.3 Pellet
  57.     4.2.4 Emulsifiable Concentrate
  58.   4.3 Healthcare, BY Target Organism (USD Million)
  59.     4.3.1 Snails
  60.     4.3.2 Slugs
  61.     4.3.3 Other Gastropods
  62.   4.4 Healthcare, BY Mode of Action (USD Million)
  63.     4.4.1 Contact
  64.     4.4.2 Ingestion
  65.     4.4.3 Systemic
  66.   4.5 Healthcare, BY Regulatory Status (USD Million)
  67.     4.5.1 Registered
  68.     4.5.2 Pending Approval
  69.     4.5.3 Banned
  70.   4.6 Healthcare, BY Region (USD Million)
  71.     4.6.1 North America
  72.       4.6.1.1 US
  73.       4.6.1.2 Canada
  74.     4.6.2 Europe
  75.       4.6.2.1 Germany
  76.       4.6.2.2 UK
  77.       4.6.2.3 France
  78.       4.6.2.4 Russia
  79.       4.6.2.5 Italy
  80.       4.6.2.6 Spain
  81.       4.6.2.7 Rest of Europe
  82.     4.6.3 APAC
  83.       4.6.3.1 China
  84.       4.6.3.2 India
  85.       4.6.3.3 Japan
  86.       4.6.3.4 South Korea
  87.       4.6.3.5 Malaysia
  88.       4.6.3.6 Thailand
  89.       4.6.3.7 Indonesia
  90.       4.6.3.8 Rest of APAC
  91.     4.6.4 South America
  92.       4.6.4.1 Brazil
  93.       4.6.4.2 Mexico
  94.       4.6.4.3 Argentina
  95.       4.6.4.4 Rest of South America
  96.     4.6.5 MEA
  97.       4.6.5.1 GCC Countries
  98.       4.6.5.2 South Africa
  99.       4.6.5.3 Rest of MEA
  100. 5 SECTION V: COMPETITIVE ANALYSIS
  101.   5.1 Competitive Landscape
  102.     5.1.1 Overview
  103.     5.1.2 Competitive Analysis
  104.     5.1.3 Market share Analysis
  105.     5.1.4 Major Growth Strategy in the Healthcare
  106.     5.1.5 Competitive Benchmarking
  107.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  108.     5.1.7 Key developments and growth strategies
  109.       5.1.7.1 New Product Launch/Service Deployment
  110.       5.1.7.2 Merger & Acquisitions
  111.       5.1.7.3 Joint Ventures
  112.     5.1.8 Major Players Financial Matrix
  113.       5.1.8.1 Sales and Operating Income
  114.       5.1.8.2 Major Players R&D Expenditure. 2023
  115.   5.2 Company Profiles
  116.     5.2.1 BASF SE (DE)
  117.       5.2.1.1 Financial Overview
  118.       5.2.1.2 Products Offered
  119.       5.2.1.3 Key Developments
  120.       5.2.1.4 SWOT Analysis
  121.       5.2.1.5 Key Strategies
  122.     5.2.2 Bayer AG (DE)
  123.       5.2.2.1 Financial Overview
  124.       5.2.2.2 Products Offered
  125.       5.2.2.3 Key Developments
  126.       5.2.2.4 SWOT Analysis
  127.       5.2.2.5 Key Strategies
  128.     5.2.3 Syngenta AG (CH)
  129.       5.2.3.1 Financial Overview
  130.       5.2.3.2 Products Offered
  131.       5.2.3.3 Key Developments
  132.       5.2.3.4 SWOT Analysis
  133.       5.2.3.5 Key Strategies
  134.     5.2.4 FMC Corporation (US)
  135.       5.2.4.1 Financial Overview
  136.       5.2.4.2 Products Offered
  137.       5.2.4.3 Key Developments
  138.       5.2.4.4 SWOT Analysis
  139.       5.2.4.5 Key Strategies
  140.     5.2.5 ADAMA Agricultural Solutions Ltd. (IL)
  141.       5.2.5.1 Financial Overview
  142.       5.2.5.2 Products Offered
  143.       5.2.5.3 Key Developments
  144.       5.2.5.4 SWOT Analysis
  145.       5.2.5.5 Key Strategies
  146.     5.2.6 Nufarm Limited (AU)
  147.       5.2.6.1 Financial Overview
  148.       5.2.6.2 Products Offered
  149.       5.2.6.3 Key Developments
  150.       5.2.6.4 SWOT Analysis
  151.       5.2.6.5 Key Strategies
  152.     5.2.7 Sumitomo Chemical Co., Ltd. (JP)
  153.       5.2.7.1 Financial Overview
  154.       5.2.7.2 Products Offered
  155.       5.2.7.3 Key Developments
  156.       5.2.7.4 SWOT Analysis
  157.       5.2.7.5 Key Strategies
  158.     5.2.8 UPL Limited (IN)
  159.       5.2.8.1 Financial Overview
  160.       5.2.8.2 Products Offered
  161.       5.2.8.3 Key Developments
  162.       5.2.8.4 SWOT Analysis
  163.       5.2.8.5 Key Strategies
  164.     5.2.9 Isagro S.p.A. (IT)
  165.       5.2.9.1 Financial Overview
  166.       5.2.9.2 Products Offered
  167.       5.2.9.3 Key Developments
  168.       5.2.9.4 SWOT Analysis
  169.       5.2.9.5 Key Strategies
  170.   5.3 Appendix
  171.     5.3.1 References
  172.     5.3.2 Related Reports
  173. 6 LIST OF FIGURES
  174.   6.1 MARKET SYNOPSIS
  175.   6.2 NORTH AMERICA MARKET ANALYSIS
  176.   6.3 US MARKET ANALYSIS BY APPLICATION
  177.   6.4 US MARKET ANALYSIS BY FORMULATION TYPE
  178.   6.5 US MARKET ANALYSIS BY TARGET ORGANISM
  179.   6.6 US MARKET ANALYSIS BY MODE OF ACTION
  180.   6.7 US MARKET ANALYSIS BY REGULATORY STATUS
  181.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  182.   6.9 CANADA MARKET ANALYSIS BY FORMULATION TYPE
  183.   6.10 CANADA MARKET ANALYSIS BY TARGET ORGANISM
  184.   6.11 CANADA MARKET ANALYSIS BY MODE OF ACTION
  185.   6.12 CANADA MARKET ANALYSIS BY REGULATORY STATUS
  186.   6.13 EUROPE MARKET ANALYSIS
  187.   6.14 GERMANY MARKET ANALYSIS BY APPLICATION
  188.   6.15 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
  189.   6.16 GERMANY MARKET ANALYSIS BY TARGET ORGANISM
  190.   6.17 GERMANY MARKET ANALYSIS BY MODE OF ACTION
  191.   6.18 GERMANY MARKET ANALYSIS BY REGULATORY STATUS
  192.   6.19 UK MARKET ANALYSIS BY APPLICATION
  193.   6.20 UK MARKET ANALYSIS BY FORMULATION TYPE
  194.   6.21 UK MARKET ANALYSIS BY TARGET ORGANISM
  195.   6.22 UK MARKET ANALYSIS BY MODE OF ACTION
  196.   6.23 UK MARKET ANALYSIS BY REGULATORY STATUS
  197.   6.24 FRANCE MARKET ANALYSIS BY APPLICATION
  198.   6.25 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
  199.   6.26 FRANCE MARKET ANALYSIS BY TARGET ORGANISM
  200.   6.27 FRANCE MARKET ANALYSIS BY MODE OF ACTION
  201.   6.28 FRANCE MARKET ANALYSIS BY REGULATORY STATUS
  202.   6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
  203.   6.30 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
  204.   6.31 RUSSIA MARKET ANALYSIS BY TARGET ORGANISM
  205.   6.32 RUSSIA MARKET ANALYSIS BY MODE OF ACTION
  206.   6.33 RUSSIA MARKET ANALYSIS BY REGULATORY STATUS
  207.   6.34 ITALY MARKET ANALYSIS BY APPLICATION
  208.   6.35 ITALY MARKET ANALYSIS BY FORMULATION TYPE
  209.   6.36 ITALY MARKET ANALYSIS BY TARGET ORGANISM
  210.   6.37 ITALY MARKET ANALYSIS BY MODE OF ACTION
  211.   6.38 ITALY MARKET ANALYSIS BY REGULATORY STATUS
  212.   6.39 SPAIN MARKET ANALYSIS BY APPLICATION
  213.   6.40 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
  214.   6.41 SPAIN MARKET ANALYSIS BY TARGET ORGANISM
  215.   6.42 SPAIN MARKET ANALYSIS BY MODE OF ACTION
  216.   6.43 SPAIN MARKET ANALYSIS BY REGULATORY STATUS
  217.   6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  218.   6.45 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
  219.   6.46 REST OF EUROPE MARKET ANALYSIS BY TARGET ORGANISM
  220.   6.47 REST OF EUROPE MARKET ANALYSIS BY MODE OF ACTION
  221.   6.48 REST OF EUROPE MARKET ANALYSIS BY REGULATORY STATUS
  222.   6.49 APAC MARKET ANALYSIS
  223.   6.50 CHINA MARKET ANALYSIS BY APPLICATION
  224.   6.51 CHINA MARKET ANALYSIS BY FORMULATION TYPE
  225.   6.52 CHINA MARKET ANALYSIS BY TARGET ORGANISM
  226.   6.53 CHINA MARKET ANALYSIS BY MODE OF ACTION
  227.   6.54 CHINA MARKET ANALYSIS BY REGULATORY STATUS
  228.   6.55 INDIA MARKET ANALYSIS BY APPLICATION
  229.   6.56 INDIA MARKET ANALYSIS BY FORMULATION TYPE
  230.   6.57 INDIA MARKET ANALYSIS BY TARGET ORGANISM
  231.   6.58 INDIA MARKET ANALYSIS BY MODE OF ACTION
  232.   6.59 INDIA MARKET ANALYSIS BY REGULATORY STATUS
  233.   6.60 JAPAN MARKET ANALYSIS BY APPLICATION
  234.   6.61 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
  235.   6.62 JAPAN MARKET ANALYSIS BY TARGET ORGANISM
  236.   6.63 JAPAN MARKET ANALYSIS BY MODE OF ACTION
  237.   6.64 JAPAN MARKET ANALYSIS BY REGULATORY STATUS
  238.   6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  239.   6.66 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
  240.   6.67 SOUTH KOREA MARKET ANALYSIS BY TARGET ORGANISM
  241.   6.68 SOUTH KOREA MARKET ANALYSIS BY MODE OF ACTION
  242.   6.69 SOUTH KOREA MARKET ANALYSIS BY REGULATORY STATUS
  243.   6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
  244.   6.71 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
  245.   6.72 MALAYSIA MARKET ANALYSIS BY TARGET ORGANISM
  246.   6.73 MALAYSIA MARKET ANALYSIS BY MODE OF ACTION
  247.   6.74 MALAYSIA MARKET ANALYSIS BY REGULATORY STATUS
  248.   6.75 THAILAND MARKET ANALYSIS BY APPLICATION
  249.   6.76 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
  250.   6.77 THAILAND MARKET ANALYSIS BY TARGET ORGANISM
  251.   6.78 THAILAND MARKET ANALYSIS BY MODE OF ACTION
  252.   6.79 THAILAND MARKET ANALYSIS BY REGULATORY STATUS
  253.   6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
  254.   6.81 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
  255.   6.82 INDONESIA MARKET ANALYSIS BY TARGET ORGANISM
  256.   6.83 INDONESIA MARKET ANALYSIS BY MODE OF ACTION
  257.   6.84 INDONESIA MARKET ANALYSIS BY REGULATORY STATUS
  258.   6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
  259.   6.86 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
  260.   6.87 REST OF APAC MARKET ANALYSIS BY TARGET ORGANISM
  261.   6.88 REST OF APAC MARKET ANALYSIS BY MODE OF ACTION
  262.   6.89 REST OF APAC MARKET ANALYSIS BY REGULATORY STATUS
  263.   6.90 SOUTH AMERICA MARKET ANALYSIS
  264.   6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
  265.   6.92 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
  266.   6.93 BRAZIL MARKET ANALYSIS BY TARGET ORGANISM
  267.   6.94 BRAZIL MARKET ANALYSIS BY MODE OF ACTION
  268.   6.95 BRAZIL MARKET ANALYSIS BY REGULATORY STATUS
  269.   6.96 MEXICO MARKET ANALYSIS BY APPLICATION
  270.   6.97 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
  271.   6.98 MEXICO MARKET ANALYSIS BY TARGET ORGANISM
  272.   6.99 MEXICO MARKET ANALYSIS BY MODE OF ACTION
  273.   6.100 MEXICO MARKET ANALYSIS BY REGULATORY STATUS
  274.   6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
  275.   6.102 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
  276.   6.103 ARGENTINA MARKET ANALYSIS BY TARGET ORGANISM
  277.   6.104 ARGENTINA MARKET ANALYSIS BY MODE OF ACTION
  278.   6.105 ARGENTINA MARKET ANALYSIS BY REGULATORY STATUS
  279.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  280.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
  281.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET ORGANISM
  282.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODE OF ACTION
  283.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY REGULATORY STATUS
  284.   6.111 MEA MARKET ANALYSIS
  285.   6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  286.   6.113 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
  287.   6.114 GCC COUNTRIES MARKET ANALYSIS BY TARGET ORGANISM
  288.   6.115 GCC COUNTRIES MARKET ANALYSIS BY MODE OF ACTION
  289.   6.116 GCC COUNTRIES MARKET ANALYSIS BY REGULATORY STATUS
  290.   6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  291.   6.118 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
  292.   6.119 SOUTH AFRICA MARKET ANALYSIS BY TARGET ORGANISM
  293.   6.120 SOUTH AFRICA MARKET ANALYSIS BY MODE OF ACTION
  294.   6.121 SOUTH AFRICA MARKET ANALYSIS BY REGULATORY STATUS
  295.   6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
  296.   6.123 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
  297.   6.124 REST OF MEA MARKET ANALYSIS BY TARGET ORGANISM
  298.   6.125 REST OF MEA MARKET ANALYSIS BY MODE OF ACTION
  299.   6.126 REST OF MEA MARKET ANALYSIS BY REGULATORY STATUS
  300.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  301.   6.128 RESEARCH PROCESS OF MRFR
  302.   6.129 DRO ANALYSIS OF HEALTHCARE
  303.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  304.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  305.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  306.   6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  307.   6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  308.   6.135 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
  309.   6.136 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
  310.   6.137 HEALTHCARE, BY TARGET ORGANISM, 2024 (% SHARE)
  311.   6.138 HEALTHCARE, BY TARGET ORGANISM, 2024 TO 2035 (USD Million)
  312.   6.139 HEALTHCARE, BY MODE OF ACTION, 2024 (% SHARE)
  313.   6.140 HEALTHCARE, BY MODE OF ACTION, 2024 TO 2035 (USD Million)
  314.   6.141 HEALTHCARE, BY REGULATORY STATUS, 2024 (% SHARE)
  315.   6.142 HEALTHCARE, BY REGULATORY STATUS, 2024 TO 2035 (USD Million)
  316.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  317. 7 LIST OF TABLES
  318.   7.1 LIST OF ASSUMPTIONS
  319.     7.1.1
  320.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  321.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  322.     7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  323.     7.2.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  324.     7.2.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  325.     7.2.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  326.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  327.     7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  328.     7.3.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  329.     7.3.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  330.     7.3.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  331.     7.3.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  332.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  333.     7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  334.     7.4.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  335.     7.4.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  336.     7.4.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  337.     7.4.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  338.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  339.     7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  340.     7.5.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  341.     7.5.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  342.     7.5.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  343.     7.5.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  344.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  345.     7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  346.     7.6.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  347.     7.6.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  348.     7.6.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  349.     7.6.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  350.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  351.     7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  352.     7.7.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  353.     7.7.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  354.     7.7.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  355.     7.7.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  356.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  357.     7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  358.     7.8.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  359.     7.8.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  360.     7.8.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  361.     7.8.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  362.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  363.     7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  364.     7.9.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  365.     7.9.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  366.     7.9.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  367.     7.9.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  368.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  369.     7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  370.     7.10.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  371.     7.10.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  372.     7.10.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  373.     7.10.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  374.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  375.     7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  376.     7.11.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  377.     7.11.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  378.     7.11.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  379.     7.11.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  380.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  381.     7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  382.     7.12.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  383.     7.12.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  384.     7.12.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  385.     7.12.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  386.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  387.     7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  388.     7.13.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  389.     7.13.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  390.     7.13.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  391.     7.13.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  392.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  393.     7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  394.     7.14.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  395.     7.14.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  396.     7.14.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  397.     7.14.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  398.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  399.     7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  400.     7.15.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  401.     7.15.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  402.     7.15.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  403.     7.15.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  404.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  405.     7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  406.     7.16.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  407.     7.16.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  408.     7.16.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  409.     7.16.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  410.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  411.     7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  412.     7.17.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  413.     7.17.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  414.     7.17.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  415.     7.17.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  416.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  417.     7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  418.     7.18.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  419.     7.18.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  420.     7.18.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  421.     7.18.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  422.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  423.     7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  424.     7.19.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  425.     7.19.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  426.     7.19.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  427.     7.19.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  428.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  429.     7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  430.     7.20.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  431.     7.20.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  432.     7.20.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  433.     7.20.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  434.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  435.     7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  436.     7.21.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  437.     7.21.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  438.     7.21.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  439.     7.21.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  440.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  441.     7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  442.     7.22.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  443.     7.22.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  444.     7.22.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  445.     7.22.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  446.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  447.     7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  448.     7.23.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  449.     7.23.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  450.     7.23.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  451.     7.23.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  452.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  453.     7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  454.     7.24.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  455.     7.24.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  456.     7.24.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  457.     7.24.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  458.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  459.     7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  460.     7.25.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  461.     7.25.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  462.     7.25.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  463.     7.25.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  464.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  465.     7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  466.     7.26.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  467.     7.26.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  468.     7.26.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  469.     7.26.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  470.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  471.     7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  472.     7.27.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  473.     7.27.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  474.     7.27.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  475.     7.27.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  476.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  477.     7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  478.     7.28.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  479.     7.28.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  480.     7.28.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  481.     7.28.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  482.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  483.     7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  484.     7.29.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  485.     7.29.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  486.     7.29.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  487.     7.29.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  488.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  489.     7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  490.     7.30.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
  491.     7.30.3 BY TARGET ORGANISM, 2025-2035 (USD Million)
  492.     7.30.4 BY MODE OF ACTION, 2025-2035 (USD Million)
  493.     7.30.5 BY REGULATORY STATUS, 2025-2035 (USD Million)
  494.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  495.     7.31.1
  496.   7.32 ACQUISITION/PARTNERSHIP
  497.     7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

  • Agriculture
  • Horticulture
  • Aquaculture
  • Public Health

Healthcare By Formulation Type (USD Million, 2025-2035)

  • Granular
  • Liquid
  • Pellet
  • Emulsifiable Concentrate

Healthcare By Target Organism (USD Million, 2025-2035)

  • Snails
  • Slugs
  • Other Gastropods

Healthcare By Mode of Action (USD Million, 2025-2035)

  • Contact
  • Ingestion
  • Systemic

Healthcare By Regulatory Status (USD Million, 2025-2035)

  • Registered
  • Pending Approval
  • Banned

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions